+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Osteoarthritis - Pipeline Review, H2 2020 - Product Thumbnail Image

Osteoarthritis - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 384 Pages
  • Global
From
Blinatumomab - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

Blinatumomab - Emerging Insight and Market Forecast - 2030

  • Report
  • February 2021
  • 50 Pages
  • Global
From
Clinical Trials Sector Scorecard - Thematic Research - Product Thumbnail Image

Clinical Trials Sector Scorecard - Thematic Research

  • Report
  • October 2021
  • 24 Pages
  • Global
From
Kidney Disease (Nephropathy) - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Kidney Disease (Nephropathy) - Global Clinical Trials Review, 2025

  • Clinical Trials
  • May 2025
  • 5100 Pages
  • Global
From
From
From
From
From
Company Snapshots: UK Pharmaceuticals - Product Thumbnail Image

Company Snapshots: UK Pharmaceuticals

  • Newsletter
  • July 2025
  • 35 Pages
  • United Kingdom
From
Loading Indicator